E. Kelley

E. Kelley

Chief Tech/Sci/R&D Officer at CNS PHARMACEUTICALS, INC.
63 year
Health Technology
Consumer Services
Consumer Non-Durables

Profile

E.
Lynne Kelley
is currently Chief Medical Officer at CNS Pharmaceuticals, Inc. since 2026 and Chief Executive & Medical Officer at Signalexis, Inc. Former positions include Chief Medical Officer at Tissium, Inc. from 2024 to 2026; Chief Medical Officer at X4 Pharmaceuticals, Inc. from 2019 to 2020; Chief Medical Officer at Histogenics Corp.
from 2018 to 2019; Vice President-Medical Affairs at Becton, Dickinson & Co. from 2011 to 2016; Medical Director at Kimberly-Clark Corp.
from 2007 to 2010; Medical Director at Boston Scientific Corp.
from 2005 to 2007; Assistant Professor at Yale University from 2003 to 2005; and Chief Medical Officer at Senseonics Holdings, Inc. Education includes undergraduate studies at Boston University and a doctorate from Dartmouth Medical School.

E. Kelley active positions

CompaniesPositionStart
CNS PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2026-03-01

Former positions of E. Kelley

CompaniesPositionEnd
X4 PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2020-04-02
OCUGEN, INC. Chief Tech/Sci/R&D Officer 2019-01-22
BECTON, DICKINSON AND COMPANY Corporate Officer/Principal 2015-12-31
KIMBERLY-CLARK CORPORATION Chief Tech/Sci/R&D Officer 2010-11-30
See the detail of E. Kelley's experience

Training of E. Kelley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

84

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Electronic Technology

Health Technology

Health Technology